ADVERTISEMENT
News
Calcium Channel Blocker Recalled
10/08/2020
The recall affects 1846 cartons of Nymalize, 60 mg/20 mL, each containing 12 unit-dose cups and 12 oral syringes (NDC 24338-200-12), from lot 356884 (Exp. 11/30/21). The cartons were distributed throughout the United States.
Arbor Pharmaceuticals voluntarily initiated the recall September 16, 2020. On September 28, 2020, the FDA designated the recall Class III, suggesting use of the recalled product is not likely to cause harm.
Nymalize is a prescription drug used to improve outcomes in adults with subarachnoid hemorrhage.
—Jolynn Tumolo
Stay Informed & Sign Up Today
Pharmacy Learning Network Newsletter
